Ergoteles LLC Beam Therapeutics Inc. Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$53.73 - $82.16 $2.39 Million - $3.66 Million
-44,574 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$68.02 - $99.06 $3.03 Million - $4.42 Million
44,574 New
44,574 $3.55 Million
Q2 2021

Aug 12, 2021
SELL
$64.12 - $128.71 $7.49 Million - $15 Million
-116,855 Closed
0 $0
Q1 2021

May 12, 2021
BUY
$71.28 - $120.75 $8.33 Million - $14.1 Million
116,855 New
116,855 $9.35 Million

Others Institutions Holding BEAM

# of Institutions
230
Shares Held
73.6M
Call Options Held
283K
Put Options Held
233K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.72B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email